Literature DB >> 22440974

DAI-10 is as good as DAI-30 in schizophrenia.

René Ernst Nielsen1, Eva Lindström, Jimmi Nielsen, Sten Levander.   

Abstract

Drug attitude inventory (DAI-30) is considered to be the best predictor of poor adherence in first-episode schizophrenia. We compared the short version (DAI-10) with DAI-30 in long-term schizophrenia, documented if DAI was associated with poor insight, PANSS and GAF and constructed DAI-10 percentiles. DAI-30 and DAI-10 were homogenous (r = 0.82 and 0.72, respectively) with good test-retest reliability (0.79). The correlation between the DAI versions was high (0.94). Percentile scores of DAI-10 were computed. DAI is an easy-to-use self-report instrument seemingly assessing a unique clinical dimension relevant to non-adherence. DAI-10 might be preferred for its simplicity and good psychometric properties.
Copyright © 2012 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440974     DOI: 10.1016/j.euroneuro.2012.02.008

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  31 in total

Review 1.  Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later.

Authors:  A George Awad
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

2.  Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.

Authors:  Christian G Widschwendter; Georg Kemmler; Maria A Rettenbacher; Nursen Yalcin-Siedentopf; Alex Hofer
Journal:  BMC Psychiatry       Date:  2018-06-28       Impact factor: 3.630

3.  Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.

Authors:  Iglika Vassileva; Vihra Milanova; Turan Asan
Journal:  Community Ment Health J       Date:  2014-01-23

4.  Time-lagged predictors of daily medication nonadherence beliefs during the month post-hospital discharge in patients with psychotic-spectrum disorders.

Authors:  Brandon A Gaudiano; Stacy Ellenberg; Lawrence H Price; Ethan Moitra
Journal:  Psychiatry Res       Date:  2018-09-21       Impact factor: 3.222

5.  The relationships between patients' and caregivers' beliefs about the causes of schizophrenia and clinical outcomes in Latin American countries.

Authors:  Alejandra Caqueo-Urízar; Laurent Boyer; Karine Baumstarck; Stephen E Gilman
Journal:  Psychiatry Res       Date:  2015-06-29       Impact factor: 3.222

6.  Lifestyle behaviors, metabolic disturbances, and weight gain in psychiatric inpatients treated with weight gain-associated medication.

Authors:  Maria S Simon; Barbara Barton; Anja Zagler; Katharina Engl; Leonora Rihs; Catherine Glocker; Richard Musil
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-01       Impact factor: 5.270

7.  Needs of Patients with Schizophrenia Among an Ethnic Minority Group in Latin America.

Authors:  Alejandra Caqueo-Urízar; Laurent Boyer; Stephen E Gilman
Journal:  J Immigr Minor Health       Date:  2017-06

8.  The validity and Reliability of the Turkish Version of Drug Attitude Inventory-10.

Authors:  Emine Aydin; Erkan Aydin; Özlem Devrim Balaban; Hüseyin Yumrukçal; Murat Erkiran
Journal:  Noro Psikiyatr Ars       Date:  2018-06-04       Impact factor: 1.339

9.  Short-term clinical stability and lack of insight are associated with a negative attitude towards antipsychotic treatment at discharge in patients with schizophrenia and bipolar disorder.

Authors:  Esteban Medina; Joan Salvà; Rubén Ampudia; Jorge Maurino; Juan Larumbe
Journal:  Patient Prefer Adherence       Date:  2012-08-29       Impact factor: 2.711

10.  Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning.

Authors:  Jose Manuel Montes; Jorge Maurino; Consuelo de Dios; Esteban Medina
Journal:  Patient Prefer Adherence       Date:  2013-01-18       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.